Literature DB >> 12661740

Hypertension in neonates causes and treatments.

Karen Kilian1.   

Abstract

Neonatal hypertension, defined as systolic blood pressure greater than 95th percentile for age, size, and gender, is an uncommon but significant problem. Hypertension may develop secondary to thromboembolic complications of central lines, steroid use, or be a sign of an underlying renal or cardiac problem. Pharmacologic management of hypertension in the neonate includes use of beta blockers, angiotensin-converting enzyme inhibitors, calcium channel blockers, and/or diuretics. This article discusses issues in assessment and management of neonatal hypertension and reviews the pharmacologic agents most commonly utilized in the neonatal setting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12661740     DOI: 10.1097/00005237-200301000-00006

Source DB:  PubMed          Journal:  J Perinat Neonatal Nurs        ISSN: 0893-2190            Impact factor:   1.638


  2 in total

1.  Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Authors:  Wael A Seliem; Michael C Falk; Bruce Shadbolt; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

2.  Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review.

Authors:  Heike Rabe; Varsha Bhatt-Mehta; Stephen A Bremner; Aisling Ahluwalia; Renske Mcfarlane; Simin Baygani; Beau Batton; Agnes Klein; Ebru Ergenekon; Luana Pesco Koplowitz; Eugene Dempsey; Dina Apele-Freimane; Hiroko Iwami; Janis M Dionne
Journal:  J Perinatol       Date:  2021-08-07       Impact factor: 2.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.